All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: Cell line-23011758

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	23011758	D474A	Env	Env	Cell line	D G	View
2	23011758	E102A	Env	Env	Cell line	G	View
3	23011758	E370A	Env	Env	Cell line	G	View
4	23011758	I371A	Env	Env	Cell line	G	View
5	23011758	K120A	Env	Env	Cell line	G	View
6	23011758	K421A	Env	Env	Cell line	G	View
7	23011758	K97A	Env	Env	Cell line	G	View
8	23011758	L122A	Env	Env	Cell line	G	View
9	23011758	M426A	Env	Env	Cell line	G	View
10	23011758	M475A	Env	Env	Cell line	G	View
11	23011758	M95A	Env	Env	Cell line	G	View
12	23011758	N98A	Env	Env	Cell line	G	View
13	23011758	N99A	Env	Env	Cell line	G	View
14	23011758	R476A	Env	Env	Cell line	G	View
15	23011758	R480A	Env	Env	Cell line	G	View
16	23011758	T257A	Env	Env	Cell line	D G	View
17	23011758	V101A	Env	Env	Cell line	G	View
18	23011758	V121A	Env	Env	Cell line	G	View
19	23011758	V255A	Env	Env	Cell line	G	View
20	23011758	V372A	Env	Env	Cell line	G	View
21	23011758	V430A	Env	Env	Cell line	G	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.